<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.4 20241031//EN" "JATS-journalpublishing1-4.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.4" xml:lang="en">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">aid</journal-id>
      <journal-title-group>
        <journal-title>Advances in Infectious Diseases</journal-title>
      </journal-title-group>
      <issn pub-type="epub">2164-2656</issn>
      <issn pub-type="ppub">2164-2648</issn>
      <publisher>
        <publisher-name>Scientific Research Publishing</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.4236/aid.2024.142027</article-id>
      <article-id pub-id-type="publisher-id">aid-133175</article-id>
      <article-categories>
        <subj-group>
          <subject>Article</subject>
        </subj-group>
        <subj-group>
          <subject>Medicine</subject>
          <subject>Healthcare</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>The COVID-19 Pandemic: Present or Gone, Where Do Adolescents Stand?</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <contrib-id contrib-id-type="orcid">0009-0009-7048-6601</contrib-id>
          <name name-style="western">
            <surname>Enadeghe</surname>
            <given-names>Ifueko</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
          <xref ref-type="aff" rid="aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">0000-0002-5681-9547</contrib-id>
          <name name-style="western">
            <surname>Sadoh</surname>
            <given-names>Ayebo</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
          <xref ref-type="aff" rid="aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Eyo-Ita</surname>
            <given-names>Emmanuel U.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Abiodun</surname>
            <given-names>Phillip O.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
      </contrib-group>
      <aff id="aff1"><label>1</label> Department of Child Health, University of Benin Teaching Hospital, Benin City, Nigeria </aff>
      <aff id="aff2"><label>2</label> Institute of Child Health, University of Benin, Benin City, Nigeria </aff>
      <author-notes>
        <fn fn-type="conflict" id="fn-conflict">
          <p>The authors declare no conflicts of interest.</p>
        </fn>
      </author-notes>
      <pub-date pub-type="epub">
        <day>25</day>
        <month>04</month>
        <year>2024</year>
      </pub-date>
      <pub-date pub-type="collection">
        <month>04</month>
        <year>2024</year>
      </pub-date>
      <volume>14</volume>
      <issue>02</issue>
      <fpage>374</fpage>
      <lpage>386</lpage>
      <history>
        <date date-type="received">
          <day>15</day>
          <month>02</month>
          <year>2024</year>
        </date>
        <date date-type="accepted">
          <day>14</day>
          <month>05</month>
          <year>2024</year>
        </date>
        <date date-type="published">
          <day>17</day>
          <month>05</month>
          <year>2024</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>© 2024 by the authors and Scientific Research Publishing Inc.</copyright-statement>
        <copyright-year>2024</copyright-year>
        <license license-type="open-access">
          <license-p> This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ( <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link> ). </license-p>
        </license>
      </permissions>
      <self-uri content-type="doi" xlink:href="https://doi.org/10.4236/aid.2024.142027">https://doi.org/10.4236/aid.2024.142027</self-uri>
      <abstract>
        <p><bold>Introduction:</bold>The initial global response to the SARS-CoV-2 pandemic focused on adults as adolescents mainly had subclinical infections. Adolescents, however, could transmit the virus and hence be a risk to the elderly, young children and immunocompromised. Adolescents are also at risk of long-term complications. This study sought to determine the prevalence of antibodies to SARS-CoV-2 among adolescents in Southern Nigeria, and to determine the association between SARS-CoV-2 seropositivity and age, gender, socioeconomic class, school type and nutritional status. <bold>Methods:</bold>This descriptive cross-sectional study was carried out in Edo state of southern Nigeria. We recruited 270 in-school adolescents aged 10 - 19 years. A WHO-adapted, pre-tested questionnaire was used to obtain data on participant history and risk factors. The questionnaire was interviewer-administered. Adolescents whose parents gave consent were recruited through a multi-stage randomized sampling method. Capillary blood for the assay was collected and analysed using a lateral-flow immunoassay device. The primary outcome was serostatus of the study. The positive predictors of serostatus were finally determined using a multiple logistics regression model. Statistical significance was set at <italic>p</italic> &lt; 0.05. <bold>Results:</bold>The seroprevalence of SARS-CoV-2 was 45.9%. IgM antibodies were found in 5.6% of participants. Older adolescents had higher seropositivity rates than younger adolescents (<italic><bold>χ</bold></italic><bold><sup>2</sup></bold> = 8.101, <italic>p</italic> = 0.017). There was no association between gender and seropositivity. Adolescents in public schools were more likely to be seropositive than those in private schools (<italic><bold>χ</bold></italic><bold><sup>2</sup></bold><bold>=</bold>25.242, <italic>p</italic> = 0.001). A higher seroprevalence was noticed among study participants in the lower socioeconomic class (<italic>x</italic><italic><sup>2</sup></italic> = 6.928, p = 0.031), and those in overcrowded classes. (<italic><bold>χ</bold></italic><bold><sup>2</sup></bold> = 79.303, <italic>p</italic> = 0.001). <bold>Conclusion:</bold>This study showed a high seroprevalence of SARS-CoV-2 among in-school adolescents. Behavioural change communication on SARS-CoV-2, vaccination of adolescents, and standardization of classrooms are recommended.</p>
      </abstract>
      <kwd-group kwd-group-type="author-generated" xml:lang="en">
        <kwd>Pandemic</kwd>
        <kwd>Adolescents</kwd>
        <kwd>Seroprevalence</kwd>
        <kwd>COVID-19</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec id="sec1">
      <title>1. Introduction</title>
      <p>The novel coronavirus took the world by surprise in December 2019, when several acute atypical respiratory tract infections were noticed in China and subsequently spread globally. [<xref ref-type="bibr" rid="B1">1</xref>] It caused a severe multisystemic disease, subsequently named the coronavirus disease 2019 (COVID-19). Within 36 months, 696 million cases and 6.6 million deaths had been reported worldwide from COVID-19 complications. A significant number of these cases (9.4 million) were reported in Africa [<xref ref-type="bibr" rid="B2">2</xref>] and Nigeria was not excluded from these complications.</p>
      <p>The initial global response was focused on adults particularly in developing countries, as most of the complications were among adults. However as the pandemic progressed, more infections were reported in children and adolescents. [<xref ref-type="bibr" rid="B3">3</xref>] These adolescents mainly had asymptomatic or subclinical COVID-19 infections. Despite their subclinical presentations, they could transmit the virus making them a risk to other age groups, especially the elderly, younger children, and immunocompromised. [<xref ref-type="bibr" rid="B4">4</xref>] These adolescents are also at risk of long-term complications, particularly the Long COVID which has been seen in adolescents regardless of the severity of the disease. The Global response to the pandemic included travel restrictions (the lockdown), physical distancing, use of face masks, hand hygiene and eventually, vaccination. Many countries including Nigeria excluded adolescents and children from the COVID-19 vaccination Programme. In Nigeria where a quarter of the estimated 213 million population are adolescents, COVID vaccination in this age group is still restricted to those needing it for international travel and education. As of 2021, with increasing vaccination coverage, many countries relaxed the very stringent COVID-19 prevention requirements. The important question of whether COVID-19 had abated, particularly in the important adolescent population who received very little attention, was however left unanswered. Till-date, pockets of cases are still being reported. In Benue State, North-Central Nigeria, 25 new cases have been alluded to by the World Health Organization (WHO). [<xref ref-type="bibr" rid="B5">5</xref>] This suggests ongoing transmission.</p>
      <p>Factors such as age, gender, socioeconomic status, and nutritional status that have been identified in some studies as being associated with seropositivity have not been comprehensively studied in adolescents. [<xref ref-type="bibr" rid="B6">6</xref>] Age and sex-disaggregated data from low and middle-income countries like Nigeria is limited. [<xref ref-type="bibr" rid="B7">7</xref>] Data from the United States Centre for Disease Control (CDC) noted that mortality arising from complications in children, was disproportionately higher in adolescents, Africans, and Hispanics. This suggests a need for further research in these subgroups. [<xref ref-type="bibr" rid="B8">8</xref>][<xref ref-type="bibr" rid="B9">9</xref>][<xref ref-type="bibr" rid="B10">10</xref>] In this study, we examined the pattern of exposure in Nigerian adolescents as documented by seropositivity and determined its association with age, gender, socioeconomic class, overcrowding, school type and nutritional status.</p>
    </sec>
    <sec id="sec2">
      <title>2. Methods</title>
      <p>STUDY DESIGN: This was a cross-sectional study recruiting study participants from 6 secondary schools across 10 wards in Benin City, South-South Nigeria. The study was conducted between August and December 2022. The study population was made up of apparently healthy adolescents aged 10 to 19 years who met the inclusion criteria. Participants were eligible for enrolment if they met the following criteria: they attended one of the participating secondary schools, were between the ages of 10 and 19 years, their parent or legal guardian gave informed consent to participate, and the child gave their assent. Children with a prior COVID-19 positive diagnosis, children whose parents did not give consent and those outside the stipulated age were excluded.</p>
      <p>Ethical clearance was obtained from the Health Research and Ethical Committee of the University of Benin Teaching Hospital (UBTH) protocol number: ADM/E22/A/VOL.1457, (see <bold>Appendix 1</bold>) and written permission was obtained from the Edo State Ministry of Education and Edo State Universal Basic Education Board (SUBEB). Participants were assured of confidentiality.</p>
      <p>SAMPLING AND DATA COLLECTION: A multistage sampling technique was used. We randomly selected 3 out of the 10 wards in the selected LGA, and 30% of the secondary schools in these wards were randomly selected. The total student population in the 6 selected schools was determined from the school registers, and our sample size of <bold>270</bold>study participants was distributed by proportion among the selected schools. A total of 270 students were recruited. </p>
      <p>Sociodemographic data was collected from the study participants using a pretested modified WHO proforma for population-based age-stratified seroepidemiological studies for SARS-CoV-2. [<xref ref-type="bibr" rid="B11">11</xref>][<xref ref-type="bibr" rid="B12">12</xref>] The questionnaire was interviewer-administered. </p>
      <p>LABORATORY ANALYSIS: Capillary blood samples were collected from the study participants by the research team and analysed using a lateral flow immunoassay device; the Unscience<sup>R</sup> COVID IgG/IgM rapid test device, an immunochromatographic test for the qualitative detection of IgM and IgG antibodies to SARS CoV2. The manufacturers reported a sensitivity of 98.81% (95% CI: 97.25%, 99.61%), and a specificity of 98.02% (95%CI: 97.05%,98.74%). Test results were classified into one of five categories: Negative, IgG positive alone, IgM positive alone, IgG and IgM positive or invalid. Invalid or ambiguous test kits were discarded, and sample collection from the participant was repeated.</p>
      <p>STATISTICAL ANALYSIS: Data obtained was analysed using Statistical Package for Social Sciences (SPSS) spreadsheet version 28. Overcrowding in homes was defined as; a couple plus a child &lt;12 years or two adults (not in a relationship) of the opposite sex sleeping in the same room. [<xref ref-type="bibr" rid="B13">13</xref>][<xref ref-type="bibr" rid="B14">14</xref>] while overcrowding in classes was defined as more than 35 students to one teacher in a standard classroom. [<xref ref-type="bibr" rid="B15">15</xref>]</p>
      <p>The primary outcome was serostatus of the study participants. The relationship between sociodemographic variables and serostatus was analysed using the chi-square test and Fisher’s Exact test where applicable.The positive predictors of serostatus were finally determined using a multiple logistics regression model. Statistical significance was set at <italic>p</italic> &lt; 0.05.</p>
    </sec>
    <sec id="sec3">
      <title>3. Results</title>
      <p>A total of two hundred and seventy (270) participants between the ages of 10 to 19 years were recruited from both public and private secondary schools. Comparisons of the sociodemographic characteristics of the participants were made based on their school type (<bold>Table 1</bold>). Adolescents were classified into age groups in line with the WHO classification. [<xref ref-type="bibr" rid="B16">16</xref>] Early adolescents accounted for 54.1% (146), middle adolescents 30% (81) and late adolescents 15.9% (43) of the study population. The study participants consisted of 111 (41.1%) males and 159 (58.9%) females, giving a male: female ratio of 1:1.4. There were 112 (41.5%) study participants from the lower socioeconomic class (SEC), 105 (38.9%) from the middle, and 53 (19.6%) from the upper socioeconomic class. None of the participants had received COVID-19 vaccination.</p>
      <p><bold>Table</bold><bold>1</bold><bold>.</bold> Sociodemographic characteristics of study participants. </p>
      <table-wrap id="tbl1">
        <label>Table 1</label>
        <table>
          <tbody>
            <tr>
              <td rowspan="2">
                <bold>Sociodemographic characteristics</bold>
              </td>
              <td colspan="2">
                <bold>Frequency</bold>
              </td>
              <td colspan="4">
                <bold>School Type</bold>
              </td>
            </tr>
            <tr>
              <td>
                <bold>n</bold>
              </td>
              <td>
                <bold>%</bold>
              </td>
              <td>
                <bold>Public</bold>
                <bold>n (%)</bold>
              </td>
              <td>
                <bold>Private</bold>
                <bold>n (%)</bold>
              </td>
              <td>
                <italic>
                  <bold>χ</bold>
                </italic>
                <bold>
                  <sup>2</sup>
                </bold>
              </td>
              <td>
                <italic>
                  <bold>p</bold>
                </italic>
              </td>
            </tr>
            <tr>
              <td>
                <bold>Adolescent group</bold>
              </td>
              <td>
              </td>
              <td>
              </td>
              <td>
              </td>
              <td>
              </td>
              <td>
              </td>
              <td>
              </td>
            </tr>
            <tr>
              <td>Early</td>
              <td>146</td>
              <td>54.1</td>
              <td>65 (44.2)</td>
              <td>81 (65.9)</td>
              <td>12.997</td>
              <td>
                <bold>0.002*</bold>
              </td>
            </tr>
            <tr>
              <td>Middle</td>
              <td>81</td>
              <td>30.0</td>
              <td>52 (35.4)</td>
              <td>29 (23.6)</td>
              <td>
              </td>
              <td>
              </td>
            </tr>
            <tr>
              <td>Late</td>
              <td>43</td>
              <td>15.9</td>
              <td>30 (20.4)</td>
              <td>13 (10.5)</td>
              <td>
              </td>
              <td>
              </td>
            </tr>
            <tr>
              <td>
                <bold>Sex</bold>
              </td>
              <td>
              </td>
              <td>
              </td>
              <td>
              </td>
              <td>
              </td>
              <td>
              </td>
              <td>
              </td>
            </tr>
            <tr>
              <td>Male</td>
              <td>111</td>
              <td>41.1</td>
              <td>61 (40.7)</td>
              <td>50 (41.5)</td>
              <td>0.020</td>
              <td>0.888</td>
            </tr>
            <tr>
              <td>Female</td>
              <td>159</td>
              <td>58.9</td>
              <td>86 (59.3)</td>
              <td>73 (58.5)</td>
              <td>
              </td>
              <td>
              </td>
            </tr>
            <tr>
              <td>
                <bold>Socioeconomic Class</bold>
              </td>
              <td>
              </td>
              <td>
              </td>
              <td>
              </td>
              <td>
              </td>
              <td>
              </td>
              <td>
              </td>
            </tr>
            <tr>
              <td>Upper</td>
              <td>53</td>
              <td>19.6</td>
              <td>7 (4.7)</td>
              <td>46 (37.4)</td>
              <td>106.672</td>
              <td>
                <bold>0.001*</bold>
              </td>
            </tr>
            <tr>
              <td>Middle</td>
              <td>105</td>
              <td>38.9</td>
              <td>39 (26.5)</td>
              <td>66 (53.7)</td>
              <td>
              </td>
              <td>
              </td>
            </tr>
            <tr>
              <td>Lower</td>
              <td>112</td>
              <td>41.5</td>
              <td>101 (68.8)</td>
              <td>11 (8.9)</td>
              <td>
              </td>
              <td>
              </td>
            </tr>
            <tr>
              <td>
                <bold>Religion</bold>
              </td>
              <td>
              </td>
              <td>
              </td>
              <td>
              </td>
              <td>
              </td>
              <td>
              </td>
              <td>
              </td>
            </tr>
            <tr>
              <td>Christian</td>
              <td>259</td>
              <td>95.9</td>
              <td>139 (94.6)</td>
              <td>120 (97.6)</td>
              <td>1.545</td>
              <td>0.214</td>
            </tr>
            <tr>
              <td>Muslim</td>
              <td>11</td>
              <td>4.1</td>
              <td>8 (5.4)</td>
              <td>3 (2.4)</td>
              <td>
              </td>
              <td>
              </td>
            </tr>
            <tr>
              <td>
                <bold>Overcrowding</bold>
              </td>
              <td>
              </td>
              <td>
              </td>
              <td>
              </td>
              <td>
              </td>
              <td>
              </td>
              <td>
              </td>
            </tr>
            <tr>
              <td>Overcrowded homes</td>
              <td>149</td>
              <td>55.2</td>
              <td>96 (64.4)</td>
              <td>53 (35.6)</td>
              <td>13.365</td>
              <td>
                <bold>0.001*</bold>
              </td>
            </tr>
            <tr>
              <td>Standard Homes</td>
              <td>121</td>
              <td>44.8</td>
              <td>51 (42.1)</td>
              <td>70 (57.9)</td>
              <td>
              </td>
              <td>
              </td>
            </tr>
            <tr>
              <td>Overcrowded Classrooms</td>
              <td>134</td>
              <td>49.6</td>
              <td>113 (84.3)</td>
              <td>21 (15.7)</td>
              <td>95.788</td>
              <td>
                <bold>0.001*</bold>
              </td>
            </tr>
            <tr>
              <td>Standard Classrooms</td>
              <td>136</td>
              <td>50.4</td>
              <td>34 (25)</td>
              <td>102 (75)</td>
              <td>
              </td>
              <td>
              </td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
      <p><italic><bold>χ</bold></italic><bold><sup>2</sup></bold>: chi-square test, p: probability. *: <italic>p</italic> &lt; 0.05 (Significant p-value).</p>
      <p>Most of the students in public schools 101 (68%) were from low socioeconomic classes compared to those in private schools who were mostly from middle 66 (53.7%) and upper 46 (37.4%) socioeconomic classes. The difference in the socioeconomic class between study participants in public and private schools was statistically significant. (<italic><bold>χ</bold></italic><bold><sup>2</sup></bold> = 106,672, <italic>p</italic> = 0.001). </p>
      <p>Overcrowding in homes was defined as; a couple plus a child &lt; 12 years or two adults (not in a relationship) of the opposite sex sleeping in the same room. [<xref ref-type="bibr" rid="B13">13</xref>][<xref ref-type="bibr" rid="B14">14</xref>] Overcrowding in classes was defined as more than 35 students to one teacher in a standard classroom. [<xref ref-type="bibr" rid="B15">15</xref>] A total of 149 students lived in overcrowded homes, of which 96 (64.4%) were from public schools, while 53 (35.6%) were from private schools. This difference was statistically significant. (<italic><bold>χ</bold></italic><bold><sup>2</sup></bold> = 13.365, <italic>p</italic> = 0.001). There were significantly more overcrowded classrooms in public schools compared to private schools. (<italic><bold>χ</bold></italic><bold><sup>2</sup></bold> = 95.788, <italic>p</italic> = 0.001). </p>
      <p>The mean weight and height of students in public schools were significantly higher than those in private schools as shown in <bold>Table</bold><bold>2</bold> (t = 2.031, <italic>p</italic> = 0.043 and 3.302, <italic>p</italic> &lt; 0.001 respectively).</p>
      <sec id="sec3dot1">
        <title>3.1. Seropositivity of the Study Participants</title>
        <p>Of the 270 study participants, 124 (45.9%) were positive for SARS-CoV-2 antibodies; either IgG, IgM, or both, while 146 (54.1%) study participants were seronegative. As seen in <xref ref-type="fig" rid="fig1">Figure 1</xref>, 109 were IgG-positive only, 2 were IgM-positive only, and 13 participants were positive for IgG and IgM. </p>
        <p><bold>Table</bold><bold>2</bold><bold>.</bold> The mean anthropometric measures of the study participants.</p>
        <table-wrap id="tbl2">
          <label>Table 2</label>
          <table>
            <tbody>
              <tr>
                <td colspan="9">Type of School</td>
              </tr>
              <tr>
                <td rowspan="2">Anthropometric measure</td>
                <td colspan="2">Public Schools</td>
                <td colspan="2">Private Schools</td>
                <td colspan="2">Total</td>
                <td rowspan="2">T-test</td>
                <td rowspan="2">
                  <italic>p</italic>
                  -value
                </td>
              </tr>
              <tr>
                <td>Mean</td>
                <td>SD</td>
                <td>Mean</td>
                <td>SD</td>
                <td>Mean</td>
                <td>SD</td>
              </tr>
              <tr>
                <td>Weight</td>
                <td>50.97</td>
                <td>11.762</td>
                <td>48.07</td>
                <td>11.664</td>
                <td>50.76</td>
                <td>20.859</td>
                <td>2.031</td>
                <td>
                  <bold>0.043*</bold>
                </td>
              </tr>
              <tr>
                <td>Height</td>
                <td>161.63</td>
                <td>10.427</td>
                <td>157.61</td>
                <td>9.333</td>
                <td>159.80</td>
                <td>10.125</td>
                <td>3.302</td>
                <td>
                  <bold>0.001*</bold>
                </td>
              </tr>
              <tr>
                <td>BMI</td>
                <td>19.33</td>
                <td>3.331</td>
                <td>19.17</td>
                <td>12.827</td>
                <td>19.26</td>
                <td>3.387</td>
                <td>0.384</td>
                <td>0.701</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
        <p>SD: Standard deviation. *: <italic>p</italic> &lt; 0.05 (Significant p-value).</p>
        <fig id="fig1">
          <label>Figure 1</label>
          <graphic xlink:href="https://html.scirp.org/file/1951031-rId15.jpeg?20251223020555" />
        </fig>
        <p><bold>Figure 1</bold><bold>.</bold> Seropositivity of study participants.</p>
      </sec>
      <sec id="sec3dot2">
        <title>3.2. Relationship between Seropositivity and Sociodemographic Characteristics</title>
        <p>There was no statistically significant difference in seropositivity between males and females (<italic><bold>χ</bold></italic><bold><sup>2</sup></bold> = 0.059, <italic>p</italic> = 0.809). Those in the late adolescent group had a higher seroprevalence of 27 (62.8%) compared to those in the middle and early adolescent groups (<bold>Table</bold><bold>3</bold>). The difference between the groups was statistically significant. (<italic><bold>χ</bold></italic><bold><sup>2</sup></bold> = 8.101, <italic>p</italic> = 0.017). In the same way, a higher seroprevalence of 55.4% was noticed among study participants in the lower socioeconomic class (<italic>x</italic><sup>2</sup> 6.928 and <italic>p</italic> = 0.031), and those in overcrowded classes 73.1%. (<italic><bold>χ</bold></italic><bold><sup>2</sup></bold> = 79.303, <italic>p</italic> = 0.001). Students in public schools and overcrowded classes were noted to have a higher seroprevalence, however, overcrowded homes did not affect the serostatus of the study participants. The most identified symptoms in </p>
        <p><bold>Table</bold><bold>3</bold><bold>.</bold> Relationship between sociodemographic factors, nutritional status, overcrowding and seropositivity to SARS-COV-2.</p>
        <table-wrap id="tbl3">
          <label>Table 3</label>
          <table>
            <tbody>
              <tr>
                <td rowspan="2">
                  <bold>Sociodemographic Variable</bold>
                </td>
                <td colspan="4">
                  <bold>Serostatus</bold>
                </td>
              </tr>
              <tr>
                <td>
                  <bold>Negative</bold>
                  <bold>n (%)</bold>
                </td>
                <td>
                  <bold>Positive</bold>
                  <bold>n (%)</bold>
                </td>
                <td>
                  <bold>χ</bold>
                  <bold>
                    <sup>2</sup>
                  </bold>
                </td>
                <td>
                  <bold>p</bold>
                </td>
              </tr>
              <tr>
                <td>
                  <bold>Adolescent group</bold>
                </td>
                <td>
                </td>
                <td>
                </td>
                <td>
                </td>
                <td>
                </td>
              </tr>
              <tr>
                <td>Early</td>
                <td>89 (61.0)</td>
                <td>57 (39.0)</td>
                <td>8.101</td>
                <td>
                  <bold>0.017*</bold>
                </td>
              </tr>
              <tr>
                <td>Middle</td>
                <td>41 (50.6)</td>
                <td>40 (49.4)</td>
                <td>
                </td>
                <td>
                </td>
              </tr>
              <tr>
                <td>Late</td>
                <td>16 (37.2)</td>
                <td>27 (62.8)</td>
                <td>
                </td>
                <td>
                </td>
              </tr>
              <tr>
                <td>
                  <bold>Socioeconomic Class</bold>
                </td>
                <td>
                </td>
                <td>
                </td>
                <td>
                </td>
                <td>
                </td>
              </tr>
              <tr>
                <td>Upper</td>
                <td>33 (62.3)</td>
                <td>20 (37.7)</td>
                <td>6.928</td>
                <td>
                  <bold>0.031*</bold>
                </td>
              </tr>
              <tr>
                <td>Middle</td>
                <td>63 (60.0)</td>
                <td>42 (40.0)</td>
                <td>
                </td>
                <td>
                </td>
              </tr>
              <tr>
                <td>Lower</td>
                <td>50 (44.6)</td>
                <td>62 (55.4)</td>
                <td>
                </td>
                <td>
                </td>
              </tr>
              <tr>
                <td>
                  <bold>Sex</bold>
                </td>
                <td>
                </td>
                <td>
                </td>
                <td>
                </td>
                <td>
                </td>
              </tr>
              <tr>
                <td>Male</td>
                <td>61 (55.0)</td>
                <td>50 (45.0)</td>
                <td>0.059</td>
                <td>0.809</td>
              </tr>
              <tr>
                <td>Female</td>
                <td>85 (53.5)</td>
                <td>74 (46.5)</td>
                <td>
                </td>
                <td>
                </td>
              </tr>
              <tr>
                <td>
                  <bold>Nutritional Status</bold>
                </td>
                <td>
                </td>
                <td>
                </td>
                <td>
                </td>
                <td>
                </td>
              </tr>
              <tr>
                <td>Severe Thinness</td>
                <td>1 (50.0)</td>
                <td>1 (50.0)</td>
                <td>1.779</td>
                <td>
                  0.679
                  <sup>†</sup>
                </td>
              </tr>
              <tr>
                <td>Thin</td>
                <td>9 (47.4)</td>
                <td>10 (52.6)</td>
                <td>
                </td>
                <td>
                </td>
              </tr>
              <tr>
                <td>Normal</td>
                <td>127 (53.8)</td>
                <td>109 (46.2)</td>
                <td>
                </td>
                <td>
                </td>
              </tr>
              <tr>
                <td>Overweight</td>
                <td>9 (69.2)</td>
                <td>4 (30.8)</td>
                <td>
                </td>
                <td>
                </td>
              </tr>
              <tr>
                <td>
                  <bold>School</bold>
                </td>
                <td>
                </td>
                <td>
                </td>
                <td>
                </td>
                <td>
                </td>
              </tr>
              <tr>
                <td>Public</td>
                <td>59 (40.1)</td>
                <td>88 (59.9)</td>
                <td>25.242</td>
                <td>
                  <bold>0.001*</bold>
                </td>
              </tr>
              <tr>
                <td>Private</td>
                <td>87 (70.7)</td>
                <td>36 (29.3)</td>
                <td>
                </td>
                <td>
                </td>
              </tr>
              <tr>
                <td>
                  <bold>Overcrowded class</bold>
                </td>
                <td>
                </td>
                <td>
                </td>
                <td>
                </td>
                <td>
                </td>
              </tr>
              <tr>
                <td>
                  <bold>No</bold>
                </td>
                <td>110 (80.9%)</td>
                <td>26 (19.1%)</td>
                <td>79.303</td>
                <td>
                  <bold>0.001*</bold>
                </td>
              </tr>
              <tr>
                <td>
                  <bold>Yes</bold>
                </td>
                <td>36 (26.9%)</td>
                <td>98 (73.1%)</td>
                <td>
                </td>
                <td>
                </td>
              </tr>
              <tr>
                <td>
                  <bold>Overcrowded Homes</bold>
                </td>
                <td>
                </td>
                <td>
                </td>
                <td>
                </td>
                <td>
                </td>
              </tr>
              <tr>
                <td>No</td>
                <td>66 (54.5)</td>
                <td>55 (45.5)</td>
                <td>0.000</td>
                <td>0.986</td>
              </tr>
              <tr>
                <td>
                  <bold>Yes</bold>
                </td>
                <td>80 (53.7)</td>
                <td>69 (46.3)</td>
                <td>
                </td>
                <td>
                </td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
        <p><sup>†</sup>Fisher’s exact test. <italic><bold>χ</bold></italic><bold><sup>2</sup></bold><bold>:</bold>chi-square test, p: probability, n: number. *: <italic>p</italic> &lt; 0.05 (Significant p-value).</p>
        <p>seropositive participants were: headaches (62.5%), fever (44.8%), malaise (33%), joint aches (24%), and chest pain (23%). In assessing risk factors associated with seropositivity, there was no statistically significant correlation between any of the symptoms and seropositivity. </p>
      </sec>
      <sec id="sec3dot3">
        <title>3.3. Independent Predictors of SARS-CoV-2 Seropositivity in Study Participants</title>
        <p><bold>Table</bold><bold>4</bold> shows the independent predictors of seropositivity following multivariate analysis. The factors that independently predicted seropositivity were learning in an overcrowded classroom and being from the late adolescent age group. </p>
      </sec>
    </sec>
    <sec id="sec4">
      <title>4. Discussion</title>
      <p>This study focused on adolescents, who make up a large percentage of the population and can serve as a reservoir for transmission. The seroprevalence obtained in this study was 45.9%. This suggests a high seropositivity to SARS-CoV-2 among adolescents in this region and is reflective of the significantly high ongoing transmission of SARS-CoV-2 within the study population. A major determinant of seropositivity has been the time interval between waves of the disease and the study period. The high seroprevalence in this study reflects the concurrent waves of the pandemic and the rising cumulative number of people exposed, with successive waves of the disease. IgM antibodies wane in the period following the wave, however IgG antibodies last for months, ranging between 6 to 18 months. The current study assessed both IgM and IgG antibodies, affording an assessment of both the recently and previously infected adolescents. Assessing </p>
      <p><bold>Table</bold><bold>4</bold><bold>.</bold> Independent predictors of SARS-CoV-2 seropositivity. </p>
      <table-wrap id="tbl4">
        <label>Table 4</label>
        <table>
          <tbody>
            <tr>
              <td rowspan="2">Variables</td>
              <td rowspan="2">AOR</td>
              <td colspan="2">
                <bold>95% C.I.</bold>
              </td>
              <td rowspan="2">
                <italic>p</italic>
              </td>
            </tr>
            <tr>
              <td>Lower</td>
              <td>Upper</td>
            </tr>
            <tr>
              <td>
                <bold>Adolescent group</bold>
              </td>
              <td>
              </td>
              <td>
              </td>
              <td>
              </td>
              <td>
              </td>
            </tr>
            <tr>
              <td>Early</td>
              <td>1.000</td>
              <td>
              </td>
              <td>
              </td>
              <td>
                <bold>0.001*</bold>
              </td>
            </tr>
            <tr>
              <td>Middle</td>
              <td>2,299</td>
              <td>1.079</td>
              <td>4,897</td>
              <td>
                <bold>0.031*</bold>
              </td>
            </tr>
            <tr>
              <td>Late</td>
              <td>6.603</td>
              <td>2.469</td>
              <td>17.465</td>
              <td>
                <bold>0.001*</bold>
              </td>
            </tr>
            <tr>
              <td>
                <bold>Overcrowded class</bold>
              </td>
              <td>
              </td>
              <td>
              </td>
              <td>
              </td>
              <td>
              </td>
            </tr>
            <tr>
              <td>No</td>
              <td>1.000</td>
              <td>
              </td>
              <td>
              </td>
              <td>
              </td>
            </tr>
            <tr>
              <td>Yes</td>
              <td>24.623</td>
              <td>10.162</td>
              <td>59.665</td>
              <td>
                <bold>0.001*</bold>
              </td>
            </tr>
            <tr>
              <td>
                <bold>School type</bold>
              </td>
              <td>
              </td>
              <td>
              </td>
              <td>
              </td>
              <td>
              </td>
            </tr>
            <tr>
              <td>Private</td>
              <td>1.000</td>
              <td>
              </td>
              <td>
              </td>
              <td>0.375</td>
            </tr>
            <tr>
              <td>Public</td>
              <td>0.665</td>
              <td>0.257</td>
              <td>1.668</td>
              <td>
              </td>
            </tr>
            <tr>
              <td>
                <bold>Socioeconomic Class</bold>
              </td>
              <td>
              </td>
              <td>
              </td>
              <td>
              </td>
              <td>
              </td>
            </tr>
            <tr>
              <td>Upper</td>
              <td>1.000</td>
              <td>
              </td>
              <td>
              </td>
              <td>0.185</td>
            </tr>
            <tr>
              <td>Middle</td>
              <td>0.758</td>
              <td>0.301</td>
              <td>1.910</td>
              <td>0.557</td>
            </tr>
            <tr>
              <td>Lower</td>
              <td>0.395</td>
              <td>0.133</td>
              <td>1.174</td>
              <td>0.095</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
      <p>C.I: confidence interval, AOR: adjusted odd ratio, p: probability. *: <italic>p</italic> &lt; 0.05 (Significant p-value).</p>
      <p>both IgG and IgM potentially contributed to the higher seroprevalence observed. [<xref ref-type="bibr" rid="B17">17</xref>] This is made obvious when comparing the prevalence reported by Okpala <italic>et</italic><italic>al</italic>. [<xref ref-type="bibr" rid="B18">18</xref>] in Anambra State, Eastern Nigeria. They reported a seroprevalence of 15.1% among adolescents, one of the lowest that has been reported among adolescents in Nigeria. Their study was done in December 2020, barely a year after the onset of the pandemic. [<xref ref-type="bibr" rid="B18">18</xref>] The higher prevalence in the current study is a result of the cumulative effect of multiple previous waves of infection. Kolawole [<xref ref-type="bibr" rid="B17">17</xref>]<italic>et al</italic><italic>.</italic> on the other hand reported a seroprevalence of 80.5% in adolescents studied between June and August 2021. Their review coincided with the onset of the second wave of the pandemic and most studies done during the pandemic like Kolawole <italic>et al</italic>., have had a higher seroprevalence. The seropositivity in the current study represents prior infection without the bias of a surge of new infections which would no doubt create a spike in seropositivity.</p>
      <p>At the time of this study, a small percentage of the study participants had IgM antibodies. The presence of IgM antibodies suggests ongoing (new) infections that show active transmission. Although COVID-19 preventive modes and restrictions had been relaxed in most states and even countries worldwide, we found that there was still significant ongoing transmission during the study period. The presence of active transmission in any community comes with the attendant risk of infection and re-infection in the populace. Okpala and co-workers [<xref ref-type="bibr" rid="B18">18</xref>] reported similar evidence of acute infection among their study population six months after the first wave of COVID-19. In both Okpala’s study and the present study, there is comparable duration after a major wave of the disease, accounting for the similarity in findings. With the resolution of a wave of disease, the fear of the spread of infection begins to resolve and both general and individual personal protective measures begin to relax. Background pockets of transmission are the facilitators of new waves of the disease. The presence of ongoing local transmission increases the risk for new waves of the disease and puts the population at risk. [19]</p>
      <p>We identified an association between the age category of the study participants and seropositivity. Participants in their late adolescence had a higher seroprevalence than those in the early and middle adolescent age group. With advancing age, adolescents are more likely to engage in risk-taking and have less parental control. [<xref ref-type="bibr" rid="B20">20</xref>] They are more exposed to the outdoors and crowded environments, and this accounts for the higher prevalence observed in the older adolescent age group. Adolescents in the older age groups are more likely to interact not just with themselves within the school environment but also with other adolescents in the community, as compared with those in the early adolescent age group who are still under close control from parents/guardians and may be more restricted. The findings in this study are in keeping with the cumulative UNICEF age-disaggregated data that showed a higher number of COVID-19 cases among late adolescents than early adolescents. [<xref ref-type="bibr" rid="B3">3</xref>] Kolawole <italic>et al</italic><italic>.</italic> also reported similar findings, their highest prevalence was in those aged 15 - 19 years. [<xref ref-type="bibr" rid="B17">17</xref>] Audu <italic>et al</italic><italic>.</italic> in Gombe State also reported a higher prevalence in adolescents aged 15 - 19 years, when compared to those aged 10 - 14 years. [21]</p>
      <p>In the current study, there was no association between gender and seropositivity. This is because both male and female adolescents are exposed to the same environment. Kolawole, Okpala, and Olaleye had similar findings. [<xref ref-type="bibr" rid="B17">17</xref>][<xref ref-type="bibr" rid="B18">18</xref>][<xref ref-type="bibr" rid="B22">22</xref>] Our findings are similar to global reports that sex does not significantly influence SARS-CoV-2 seropositivity and transmissibility. The World Health Organization and the African Centre for Disease Control indicated that gender has no role in SARS-CoV-2 seropositivity. </p>
      <p>We found no statistically significant difference in seropositivity concerning different nutritional status. Few studies have assessed the relationship between seropositivity and nutritional status. Nwosu <italic>et al</italic> in their study noted higher seroprevalence in obese individuals. [<xref ref-type="bibr" rid="B23">23</xref>] Studies have suggested that a positive correlation between obesity and seropositivity may be related to severe illness, which is more common in obese individuals and linked to longer-lasting antibody responses. [<xref ref-type="bibr" rid="B23">23</xref>] These findings are further buttressed by Karachaliou <italic>et al</italic> in Spain who demonstrated that obese people had higher positive responses. [<xref ref-type="bibr" rid="B24">24</xref>] However, after adjustments were made for the severity of infection, associations were largely diluted. Although Karachaliou <italic>et al</italic><italic>.</italic> noted higher seroprevalence among obese individuals, the current study did not have any obese participants and did not observe any relationship between seropositivity and nutritional status. Most of the study participants had normal stature with only a few being overweight or thin. This might account for the lack of significant difference as most of the study population clustered within the normal BMI group.</p>
      <p>In the present study, participants in the lower socioeconomic class had higher seropositivity than those in the higher and middle classes. This finding was also reported by Indenbaum in Israel, and Ferreira in Brazil. [<xref ref-type="bibr" rid="B25">25</xref>][<xref ref-type="bibr" rid="B26">26</xref>] The higher seropositivity in adolescents of lower socioeconomic class may be linked to higher attendance at public schools by these adolescents. These public schools are often overcrowded, a factor that was noted to independently predict seropositivity in this study. The pattern of housing in overcrowded suburban regions occupied by those in the lower socioeconomic classes may also be a factor. Overcrowding increases the likelihood of transmission via respiratory droplets. Of note was that overcrowding in schools with other students from different homes was even more of a contributor than overcrowding at home with members of the same family. Also, adolescents from the lower socioeconomic class may have limited ability to acquire personal protective materials hence increasing the chances of transmission among them. The role of social distancing and the use of personal protective material in the prevention of SARS-CoV-2 transmission have been alluded to in previous studies.</p>
    </sec>
    <sec id="sec5">
      <title>5. Conclusion and Recommendations</title>
      <p>Despite the low reports of COVID-19 in Nigeria, there is a high seroprevalence of SARS-CoV-2 antibodies among adolescents in Benin City. Adolescents in overcrowded classrooms, older adolescents and those from lower socio-economic classes are more likely to be seropositive. Transmission remains ongoing among the adolescent population who may serve as the source of the infection for their vulnerable parents and other elderly persons in their homes. </p>
      <p>There is a need to review the Nigerian COVID-19 immunization policy to include adolescents. Clinicians should maintain a high index of suspicion and include testing for SARS-CoV-2 in adolescents who present with respiratory illness and symptoms simulating post-COVID sequelae. </p>
      <p>There should be continued public protective measures to mitigate the spread of the infection and reduce ongoing transmission. </p>
      <p>The recommended student: Teacher ratio for classrooms of 1 teacher to 35 students, should be maintained to avoid overcrowded school settings that could set the stage for the spread of infection. </p>
      <p>Similar studies should be replicated in a multi-site research to generate representative national data. In addition, more studies should be carried out on the impact of nutrition on SARS-CoV-2 Seropositivity. </p>
    </sec>
    <sec id="sec6">
      <title>6. Limitations</title>
      <p>This study was conducted when nations had lifted COVID-19 restrictions, and most communities had relaxed most preventive measures, which could impact the outcome of the study. </p>
    </sec>
    <sec id="sec7">
      <title>Author Contributions</title>
      <p>IAE—conceptualization of the study and study design, data collection and entry, sample collection and analysis, interpretation of data, writing of draft and final approval of the version to be published.</p>
      <p>AES—conceptualization and review of study design, interpretation of data, revision of draft critically for important intellectual content; and final approval of the version to be published. </p>
      <p>EUE—conceptualization and study design, data collection and entry, sample collection and analysis, interpretation of data, revision of draft critically for important intellectual content and final approval of the version to be published. </p>
      <p>POA—revision of the draft critically for important intellectual content; and final approval of the version to be published</p>
      <p>All authors read and approved the final manuscript.</p>
    </sec>
    <sec id="sec8">
      <title>Ethics Approval and Consent to Participate</title>
      <p>This study was performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. The research was reviewed and approved by the University of Benin Teaching Hospital Ethics Health and Research Committee (protocol number: ADM/E22/A/VOL.1457). (Appendix I) Signed informed consent was obtained from caregivers of the study participants after the purpose of the study was explained to them and participation was voluntary. </p>
    </sec>
    <sec id="sec9">
      <title>Funding</title>
      <p>The research was self-funded by the authors and no funding was received from any funding body or organization.</p>
    </sec>
    <sec id="sec10">
      <title>Acknowledgement</title>
      <p>The authors would like to thank Dr. P.E. Ikhurionan for his contributions to statistical analysis and proofreading of this work. Special thanks to Mr. Igbarumah, for his assistance with the University Virological research lab. We would also like to acknowledge Dr. C. Solomon for her assistance with data collection.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>References</title>
      <ref id="B1">
        <label>1.</label>
        <citation-alternatives>
          <mixed-citation publication-type="journal">Yuki, K., Fujiogi, M. and Koutsogiannaki, S. (2020) COVID-19 Pathophysiology: A Review. <italic>Clinical Immunology</italic>, 215, Article ID: 108427. https://doi.org/10.1016/j.clim.2020.108427 <pub-id pub-id-type="doi">10.1016/j.clim.2020.108427</pub-id><pub-id pub-id-type="pmid">32325252</pub-id><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.clim.2020.108427">https://doi.org/10.1016/j.clim.2020.108427</ext-link></mixed-citation>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <string-name>Yuki, K.</string-name>
              <string-name>Fujiogi, M.</string-name>
              <string-name>Koutsogiannaki, S.</string-name>
            </person-group>
            <year>2020</year>
            <article-title>COVID-19 Pathophysiology: A Review</article-title>
            <source>Clinical Immunology</source>
            <volume>215</volume>
            <fpage>108427</fpage>
            <elocation-id>ID</elocation-id>
            <pub-id pub-id-type="doi">10.1016/j.clim.2020.108427</pub-id>
            <pub-id pub-id-type="pmid">32325252</pub-id>
          </element-citation>
        </citation-alternatives>
      </ref>
      <ref id="B2">
        <label>2.</label>
        <citation-alternatives>
          <mixed-citation publication-type="other">Elimian, K.O., Ochu, C.L., Ilori, E., Oladejo, J., Igumbor, E., Steinhardt, L., <italic>et al</italic>. (2020) Descriptive Epidemiology of Coronavirus Disease 2019 in Nigeria, 27 February-6 June 2020. <italic>Epidemiology and Infection</italic>, 148, e208. https://doi.org/10.1017/S095026882000206X <pub-id pub-id-type="doi">10.1017/S095026882000206X</pub-id><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1017/S095026882000206X">https://doi.org/10.1017/S095026882000206X</ext-link></mixed-citation>
          <element-citation publication-type="other">
            <person-group person-group-type="author">
              <string-name>Elimian, K.O.</string-name>
              <string-name>Ochu, C.L.</string-name>
              <string-name>Ilori, E.</string-name>
              <string-name>Oladejo, J.</string-name>
              <string-name>Igumbor, E.</string-name>
              <string-name>Steinhardt, L.</string-name>
            </person-group>
            <year>2020</year>
            <article-title>Descriptive Epidemiology of Coronavirus Disease 2019 in Nigeria, 27 February-6 June 2020</article-title>
            <source>Epidemiology and Infection</source>
            <volume>148</volume>
            <pub-id pub-id-type="doi">10.1017/S095026882000206X</pub-id>
          </element-citation>
        </citation-alternatives>
      </ref>
      <ref id="B3">
        <label>3.</label>
        <citation-alternatives>
          <mixed-citation publication-type="web">UNICEF (2022) COVID-19 Confirmed Cases and Deaths—UNICEF DATA. https://data.unicef.org/resources/covid-19-confirmed-cases-and-deaths-dashboard/</mixed-citation>
          <element-citation publication-type="web">
            <year>2022</year>
            <article-title>COVID-19 Confirmed Cases and Deaths—UNICEF DATA</article-title>
          </element-citation>
        </citation-alternatives>
      </ref>
      <ref id="B4">
        <label>4.</label>
        <citation-alternatives>
          <mixed-citation publication-type="other">Park, Y.J., Choe, Y.J., Park, O., Park, S.Y., Kim, Y.M., Kim, J., <italic>et al</italic>. (2020) Contact Tracing during Coronavirus Disease Outbreak, South Korea, 2020. <italic>Emerging Infectious Diseases</italic>, 26, 2465-2468. https://doi.org/10.3201/eid2610.201315 <pub-id pub-id-type="doi">10.3201/eid2610.201315</pub-id><pub-id pub-id-type="pmid">32673193</pub-id><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3201/eid2610.201315">https://doi.org/10.3201/eid2610.201315</ext-link></mixed-citation>
          <element-citation publication-type="other">
            <person-group person-group-type="author">
              <string-name>Park, Y.J.</string-name>
              <string-name>Choe, Y.J.</string-name>
              <string-name>Park, O.</string-name>
              <string-name>Park, S.Y.</string-name>
              <string-name>Kim, Y.M.</string-name>
              <string-name>Kim, J.</string-name>
              <string-name>Outbreak, S</string-name>
            </person-group>
            <year>2020</year>
            <article-title>Contact Tracing during Coronavirus Disease Outbreak, South Korea, 2020</article-title>
            <source>Emerging Infectious Diseases</source>
            <volume>26</volume>
            <pub-id pub-id-type="doi">10.3201/eid2610.201315</pub-id>
            <pub-id pub-id-type="pmid">32673193</pub-id>
          </element-citation>
        </citation-alternatives>
      </ref>
      <ref id="B5">
        <label>5.</label>
        <citation-alternatives>
          <mixed-citation publication-type="web">NCDC (2023) Nigeria Centre for Disease Control and Prevention Protecting the Health of Nigerians. https://ncdc.gov.ng/news/505/official-statement-to-the-news-on-covid-19-resurgence-in-benue-state</mixed-citation>
          <element-citation publication-type="web">
            <year>2023</year>
            <article-title>Nigeria Centre for Disease Control and Prevention Protecting the Health of Nigerians</article-title>
          </element-citation>
        </citation-alternatives>
      </ref>
      <ref id="B6">
        <label>6.</label>
        <citation-alternatives>
          <mixed-citation publication-type="web">World Health Organization (2021) Advice on the Use of Point-of-Care Immunodiagnostic Tests for COVID-19. https://www.who.int/news-room/commentaries/detail/advice-on-the-use-of-point-of-care-immunodiagnostic-tests-for-covid-19</mixed-citation>
          <element-citation publication-type="web">
            <year>2021</year>
            <article-title>Advice on the Use of Point-of-Care Immunodiagnostic Tests for COVID-19</article-title>
          </element-citation>
        </citation-alternatives>
      </ref>
      <ref id="B7">
        <label>7.</label>
        <citation-alternatives>
          <mixed-citation publication-type="web">UNICEF (2022) Child Mortality and COVID-19. UNICEF Data. https://data.unicef.org/topic/child-survival/covid-19/</mixed-citation>
          <element-citation publication-type="web">
            <year>2022</year>
            <article-title>Child Mortality and COVID-19</article-title>
          </element-citation>
        </citation-alternatives>
      </ref>
      <ref id="B8">
        <label>8.</label>
        <citation-alternatives>
          <mixed-citation publication-type="other">Roberts, J.E., Campbell, J.I., Gauvreau, K., Lamb, G.S., Newburger, J., Son, M.B., <italic>et al</italic>. (2022) Differentiating Multisystem Inflammatory Syndrome in Children: A Single-Centre Retrospective Cohort Study. <italic>Archives of Disease in Childhood</italic>, 107, e3. https://adc.bmj.com/content/107/3/e3 https://doi.org/10.1136/archdischild-2021-322290 <pub-id pub-id-type="doi">10.1136/archdischild-2021-322290</pub-id><pub-id pub-id-type="pmid">34244164</pub-id><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1136/archdischild-2021-322290">https://doi.org/10.1136/archdischild-2021-322290</ext-link></mixed-citation>
          <element-citation publication-type="other">
            <person-group person-group-type="author">
              <string-name>Roberts, J.E.</string-name>
              <string-name>Campbell, J.I.</string-name>
              <string-name>Gauvreau, K.</string-name>
              <string-name>Lamb, G.S.</string-name>
              <string-name>Newburger, J.</string-name>
              <string-name>Son, M.B.</string-name>
            </person-group>
            <year>2022</year>
            <article-title>Differentiating Multisystem Inflammatory Syndrome in Children: A Single-Centre Retrospective Cohort Study</article-title>
            <source>Archives of Disease in Childhood</source>
            <volume>107</volume>
            <pub-id pub-id-type="doi">10.1136/archdischild-2021-322290</pub-id>
            <pub-id pub-id-type="pmid">34244164</pub-id>
          </element-citation>
        </citation-alternatives>
      </ref>
      <ref id="B9">
        <label>9.</label>
        <citation-alternatives>
          <mixed-citation publication-type="report">Moore, J.T., Ricaldi, J.N., Rose, C.E., Fuld, J., Parise, M., Kang, G.J., <italic>et al</italic>. (2020) Disparities in Incidence of COVID-19 among Underrepresented Racial/Ethnic Groups in Counties Identified as Hotspots during June 5-18, 2020—22 States, February-June 2020. <italic>Morbidity and Mortality Weekly Report</italic>, 69, 1122-1126.</mixed-citation>
          <element-citation publication-type="report">
            <person-group person-group-type="author">
              <string-name>Moore, J.T.</string-name>
              <string-name>Ricaldi, J.N.</string-name>
              <string-name>Rose, C.E.</string-name>
              <string-name>Fuld, J.</string-name>
              <string-name>Parise, M.</string-name>
              <string-name>Kang, G.J.</string-name>
              <string-name>States, F</string-name>
            </person-group>
            <year>2020</year>
            <article-title>Disparities in Incidence of COVID-19 among Underrepresented Racial/Ethnic Groups in Counties Identified as Hotspots during June 5-18, 2020—22 States, February-June 2020</article-title>
            <source>Morbidity and Mortality Weekly Report</source>
            <volume>69</volume>
          </element-citation>
        </citation-alternatives>
      </ref>
      <ref id="B10">
        <label>10.</label>
        <citation-alternatives>
          <mixed-citation publication-type="journal">Danae, B., Allison, M. and Claire, M. (2020) CDC: 74% of Children Who Died from SARS-CoV-2 Are Hispanic, Black. AAP News. https://publications.aap.org/aapnews/news/8093/CDC-74-of-children-who-died-from-SARS-CoV-2-are?searchresult=1&amp;utm_source=TrendMD&amp;utm_medium=TrendMD&amp;utm_campaign=AAPNews_TrendMD_0</mixed-citation>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <string-name>Danae, B.</string-name>
              <string-name>Allison, M.</string-name>
              <string-name>Claire, M.</string-name>
              <string-name>Hispanic, B</string-name>
            </person-group>
            <year>2020</year>
            <article-title>CDC: 74% of Children Who Died from SARS-CoV-2 Are Hispanic, Black</article-title>
            <fpage>74</fpage>
          </element-citation>
        </citation-alternatives>
      </ref>
      <ref id="B11">
        <label>11.</label>
        <citation-alternatives>
          <mixed-citation publication-type="web">World Health Organization (2020) Population-Based Age-Stratified Seroepidemiological Investigation Protocol for Coronavirus 2019 (COVID-19) Infection. https://iris.who.int/handle/10665/331656</mixed-citation>
          <element-citation publication-type="web">
            <year>2020</year>
            <article-title>Population-Based Age-Stratified Seroepidemiological Investigation Protocol for Coronavirus 2019 (COVID-19) Infection</article-title>
          </element-citation>
        </citation-alternatives>
      </ref>
      <ref id="B12">
        <label>12.</label>
        <citation-alternatives>
          <mixed-citation publication-type="web">WHO Regional Office for Europe (2020) COVID-19 Snapshot Monitoring (COSMO Standard): Monitoring Knowledge, Risk Perceptions, Preventive Behaviours, and Public Trust in the Current Coronavirus Outbreak—WHO Standard Protocol. https://psycharchives.org/en/item/62216bdb-69fa-44e7-92b4-8438b3817341</mixed-citation>
          <element-citation publication-type="web">
            <person-group person-group-type="author">
              <string-name>Knowledge, R</string-name>
              <string-name>Perceptions, P</string-name>
            </person-group>
            <year>2020</year>
            <article-title>COVID-19 Snapshot Monitoring (COSMO Standard): Monitoring Knowledge, Risk Perceptions, Preventive Behaviours, and Public Trust in the Current Coronavirus Outbreak—WHO Standard Protocol</article-title>
          </element-citation>
        </citation-alternatives>
      </ref>
      <ref id="B13">
        <label>13.</label>
        <citation-alternatives>
          <mixed-citation publication-type="journal">Yetunderonke, O. (2015) A Study of Housing Adequacy of Multi-Habited Houses in a Typical Nigerian Town. <italic>International Journal of Advanced and Multidisciplinary Social Science</italic>, 1, 7-12. http://journal.sapub.org/jamss</mixed-citation>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <string-name>Yetunderonke, O.</string-name>
            </person-group>
            <year>2015</year>
            <article-title>A Study of Housing Adequacy of Multi-Habited Houses in a Typical Nigerian Town</article-title>
            <source>International Journal of Advanced and Multidisciplinary Social Science</source>
            <volume>1</volume>
          </element-citation>
        </citation-alternatives>
      </ref>
      <ref id="B14">
        <label>14.</label>
        <citation-alternatives>
          <mixed-citation publication-type="web">World Health Organization (2018) WHO Housing and Health Guidelines. https://www.who.int/publications/i/item/9789241550376</mixed-citation>
          <element-citation publication-type="web">
            <year>2018</year>
            <article-title>WHO Housing and Health Guidelines</article-title>
          </element-citation>
        </citation-alternatives>
      </ref>
      <ref id="B15">
        <label>15.</label>
        <citation-alternatives>
          <mixed-citation publication-type="book">UNESCO (2006) UNESCO IBE—World Data on Education, 6th Edition. https://unesdoc.unesco.org/ark:/48223/pf0000379618</mixed-citation>
          <element-citation publication-type="book">
            <year>2006</year>
            <article-title>UNESCO IBE—World Data on Education, 6th Edition</article-title>
          </element-citation>
        </citation-alternatives>
      </ref>
      <ref id="B16">
        <label>16.</label>
        <citation-alternatives>
          <mixed-citation publication-type="web">WHO (2014) Adolescence: A Period Needing Special Attention—Age-Not-the-Whole-Story. https://apps.who.int/adolescent/second-decade/section2/page2/age-not-the-whole-story.html</mixed-citation>
          <element-citation publication-type="web">
            <year>2014</year>
            <article-title>Adolescence: A Period Needing Special Attention—Age-Not-the-Whole-Story</article-title>
          </element-citation>
        </citation-alternatives>
      </ref>
      <ref id="B17">
        <label>17.</label>
        <citation-alternatives>
          <mixed-citation publication-type="other">Kolawole, O.M., Tomori, O., Agbonlahor, D., Ekanem, E., Bakare, R., Abdulsalam, N., <italic>et al</italic>. (2022) SARS CoV-2 Seroprevalence in Selected States of High and Low Disease Burden in Nigeria. <italic>JAMA Netw</italic><italic>ork</italic><italic>Open</italic>, 5, e2236053. https://doi.org/10.1001/jamanetworkopen.2022.36053 <pub-id pub-id-type="doi">10.1001/jamanetworkopen.2022.36053</pub-id><pub-id pub-id-type="pmid">36219441</pub-id><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1001/jamanetworkopen.2022.36053">https://doi.org/10.1001/jamanetworkopen.2022.36053</ext-link></mixed-citation>
          <element-citation publication-type="other">
            <person-group person-group-type="author">
              <string-name>Kolawole, O.M.</string-name>
              <string-name>Tomori, O.</string-name>
              <string-name>Agbonlahor, D.</string-name>
              <string-name>Ekanem, E.</string-name>
              <string-name>Bakare, R.</string-name>
              <string-name>Abdulsalam, N.</string-name>
            </person-group>
            <year>2022</year>
            <article-title>SARS CoV-2 Seroprevalence in Selected States of High and Low Disease Burden in Nigeria</article-title>
            <source>JAMA Network Open</source>
            <volume>5</volume>
            <pub-id pub-id-type="doi">10.1001/jamanetworkopen.2022.36053</pub-id>
            <pub-id pub-id-type="pmid">36219441</pub-id>
          </element-citation>
        </citation-alternatives>
      </ref>
      <ref id="B18">
        <label>18.</label>
        <citation-alternatives>
          <mixed-citation publication-type="journal">Okpala, O.V., Dim, C.C., Ugwu, C.I., Onyemaechi, S., Uchebo, O., Chukwulobelu, U., <italic>et al</italic>. (2021) Population Seroprevalence of SARS-CoV-2 Antibodies in Anambra State, South-East, Nigeria. <italic>International Journal of Infectious Diseases</italic>, 110, 171-178. https://doi.org/10.1016/j.ijid.2021.07.040 <pub-id pub-id-type="doi">10.1016/j.ijid.2021.07.040</pub-id><pub-id pub-id-type="pmid">34293489</pub-id><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.ijid.2021.07.040">https://doi.org/10.1016/j.ijid.2021.07.040</ext-link></mixed-citation>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <string-name>Okpala, O.V.</string-name>
              <string-name>Dim, C.C.</string-name>
              <string-name>Ugwu, C.I.</string-name>
              <string-name>Onyemaechi, S.</string-name>
              <string-name>Uchebo, O.</string-name>
              <string-name>Chukwulobelu, U.</string-name>
              <string-name>State, S</string-name>
              <string-name>East, N</string-name>
            </person-group>
            <year>2021</year>
            <article-title>Population Seroprevalence of SARS-CoV-2 Antibodies in Anambra State, South-East, Nigeria</article-title>
            <source>International Journal of Infectious Diseases</source>
            <volume>110</volume>
            <pub-id pub-id-type="doi">10.1016/j.ijid.2021.07.040</pub-id>
            <pub-id pub-id-type="pmid">34293489</pub-id>
          </element-citation>
        </citation-alternatives>
      </ref>
      <ref id="B19">
        <label>19.</label>
        <citation-alternatives>
          <mixed-citation publication-type="web">Cennimo, J.D., Bergman, S.J. and Olsen, K.M. (2022) Coronavirus Disease 2019 (COVID-19): Practice Essentials, Background, Route of Transmission. https://emedicine.medscape.com/article/2500114-overview</mixed-citation>
          <element-citation publication-type="web">
            <person-group person-group-type="author">
              <string-name>Cennimo, J.D.</string-name>
              <string-name>Bergman, S.J.</string-name>
              <string-name>Olsen, K.M.</string-name>
              <string-name>Essentials, B</string-name>
            </person-group>
            <year>2022</year>
            <article-title>Coronavirus Disease 2019 (COVID-19): Practice Essentials, Background, Route of Transmission</article-title>
          </element-citation>
        </citation-alternatives>
      </ref>
      <ref id="B20">
        <label>20.</label>
        <citation-alternatives>
          <mixed-citation publication-type="other">Steinberg, L. (2008) A Social Neuroscience Perspective on Adolescent Risk-Taking. <italic>Developmental Review</italic>, 28, 78-106. https://doi.org/10.1016/j.dr.2007.08.002 <pub-id pub-id-type="doi">10.1016/j.dr.2007.08.002</pub-id><pub-id pub-id-type="pmid">18509515</pub-id><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.dr.2007.08.002">https://doi.org/10.1016/j.dr.2007.08.002</ext-link></mixed-citation>
          <element-citation publication-type="other">
            <person-group person-group-type="author">
              <string-name>Steinberg, L.</string-name>
            </person-group>
            <year>2008</year>
            <article-title>A Social Neuroscience Perspective on Adolescent Risk-Taking</article-title>
            <source>Developmental Review</source>
            <volume>28</volume>
            <pub-id pub-id-type="doi">10.1016/j.dr.2007.08.002</pub-id>
            <pub-id pub-id-type="pmid">18509515</pub-id>
          </element-citation>
        </citation-alternatives>
      </ref>
      <ref id="B21">
        <label>21.</label>
        <citation-alternatives>
          <mixed-citation publication-type="journal">Audu, R.A., Stafford, K.A., Steinhardt, L., Musa, Z.A., Iriemenam, N., Ilori, E., <italic>et al</italic>. (2022) Seroprevalence of SARS-CoV-2 in Four States of Nigeria in October 2020: A Population-Based Household Survey. <italic>PLOS Global Public Health</italic>, 2, e0000363. https://journals.plos.org/globalpublichealth/article?id=10.1371/journal.pgph.0000363 https://doi.org/10.1371/journal.pgph.0000363 <pub-id pub-id-type="doi">10.1371/journal.pgph.0000363</pub-id><pub-id pub-id-type="pmid">36962359</pub-id><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pgph.0000363">https://doi.org/10.1371/journal.pgph.0000363</ext-link></mixed-citation>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <string-name>Audu, R.A.</string-name>
              <string-name>Stafford, K.A.</string-name>
              <string-name>Steinhardt, L.</string-name>
              <string-name>Musa, Z.A.</string-name>
              <string-name>Iriemenam, N.</string-name>
              <string-name>Ilori, E.</string-name>
            </person-group>
            <year>2022</year>
            <article-title>Seroprevalence of SARS-CoV-2 in Four States of Nigeria in October 2020: A Population-Based Household Survey</article-title>
            <source>PLOS Global Public Health</source>
            <volume>2</volume>
            <pub-id pub-id-type="doi">10.1371/journal.pgph.0000363</pub-id>
            <pub-id pub-id-type="pmid">36962359</pub-id>
          </element-citation>
        </citation-alternatives>
      </ref>
      <ref id="B22">
        <label>22.</label>
        <citation-alternatives>
          <mixed-citation publication-type="other">Olaleye, D., Aminu, M., Olusola, B., Segun, T., Faneye, A., Opayele, A., <italic>et al</italic>. (2022) High Seroprevalence of SARS-COV-2 Antibody before Covid-19 Vaccination in Nigerian Communities. <italic>International Archives of Public Health and Community Medicine</italic>, 6, Article 83. https://doi.org/10.23937/2643-4512/1710083 <pub-id pub-id-type="doi">10.23937/2643-4512/1710083</pub-id><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.23937/2643-4512/1710083">https://doi.org/10.23937/2643-4512/1710083</ext-link></mixed-citation>
          <element-citation publication-type="other">
            <person-group person-group-type="author">
              <string-name>Olaleye, D.</string-name>
              <string-name>Aminu, M.</string-name>
              <string-name>Olusola, B.</string-name>
              <string-name>Segun, T.</string-name>
              <string-name>Faneye, A.</string-name>
              <string-name>Opayele, A.</string-name>
            </person-group>
            <year>2022</year>
            <article-title>High Seroprevalence of SARS-COV-2 Antibody before Covid-19 Vaccination in Nigerian Communities</article-title>
            <source>International Archives of Public Health and Community Medicine</source>
            <volume>6</volume>
            <elocation-id>83</elocation-id>
            <pub-id pub-id-type="doi">10.23937/2643-4512/1710083</pub-id>
          </element-citation>
        </citation-alternatives>
      </ref>
      <ref id="B23">
        <label>23.</label>
        <citation-alternatives>
          <mixed-citation publication-type="other">Nwosu, K., Fokam, J., Wanda, F., Mama, L., Orel, E., Ray, N., <italic>et al</italic>. (2021) SARS-CoV-2 Antibody Seroprevalence and Associated Risk Factors in an Urban District in Cameroon. <italic>Nature Communications</italic>, 12, Article No. 5851. https://doi.org/10.1038/s41467-021-25946-0 <pub-id pub-id-type="doi">10.1038/s41467-021-25946-0</pub-id><pub-id pub-id-type="pmid">34615863</pub-id><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/s41467-021-25946-0">https://doi.org/10.1038/s41467-021-25946-0</ext-link></mixed-citation>
          <element-citation publication-type="other">
            <person-group person-group-type="author">
              <string-name>Nwosu, K.</string-name>
              <string-name>Fokam, J.</string-name>
              <string-name>Wanda, F.</string-name>
              <string-name>Mama, L.</string-name>
              <string-name>Orel, E.</string-name>
              <string-name>Ray, N.</string-name>
            </person-group>
            <year>2021</year>
            <article-title>SARS-CoV-2 Antibody Seroprevalence and Associated Risk Factors in an Urban District in Cameroon</article-title>
            <source>Nature Communications</source>
            <volume>12</volume>
            <elocation-id>No</elocation-id>
            <pub-id pub-id-type="doi">10.1038/s41467-021-25946-0</pub-id>
            <pub-id pub-id-type="pmid">34615863</pub-id>
          </element-citation>
        </citation-alternatives>
      </ref>
      <ref id="B24">
        <label>24.</label>
        <citation-alternatives>
          <mixed-citation publication-type="other">Karachaliou, M., Moncunill, G., Espinosa, A., Castaño-Vinyals, G., Jiménez, A., Vidal, M., <italic>et al</italic>. (2021) Infection Induced SARS-CoV-2 Seroprevalence and Heterogeneity of Antibody Responses in a General Population Cohort Study in Catalonia Spain. <italic>Scientific Reports</italic>, 11, Article No. 21571. https://doi.org/10.1038/s41598-021-00807-4 <pub-id pub-id-type="doi">10.1038/s41598-021-00807-4</pub-id><pub-id pub-id-type="pmid">34732749</pub-id><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/s41598-021-00807-4">https://doi.org/10.1038/s41598-021-00807-4</ext-link></mixed-citation>
          <element-citation publication-type="other">
            <person-group person-group-type="author">
              <string-name>Karachaliou, M.</string-name>
              <string-name>Moncunill, G.</string-name>
              <string-name>Espinosa, A.</string-name>
              <string-name>Vinyals, G.</string-name>
              <string-name>Vidal, M.</string-name>
            </person-group>
            <year>2021</year>
            <article-title>Infection Induced SARS-CoV-2 Seroprevalence and Heterogeneity of Antibody Responses in a General Population Cohort Study in Catalonia Spain</article-title>
            <source>Scientific Reports</source>
            <volume>11</volume>
            <elocation-id>No</elocation-id>
            <pub-id pub-id-type="doi">10.1038/s41598-021-00807-4</pub-id>
            <pub-id pub-id-type="pmid">34732749</pub-id>
          </element-citation>
        </citation-alternatives>
      </ref>
      <ref id="B25">
        <label>25.</label>
        <citation-alternatives>
          <mixed-citation publication-type="journal">Indenbaum, V., Lustig, Y., Mendelson, E., Hershkovitz, Y., Glatman-Freedman, A., Keinan-Boker, L., <italic>et al</italic>. (2021) Under-Diagnosis of SARS-CoV-2 Infections among Children Aged 0-15 Years, a Nationwide Seroprevalence Study, Israel, January 2020 to March 2021. <italic>Eurosurveillance</italic>, 26, Article ID: 2101040. https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2021.26.48.2101040 https://doi.org/10.2807/1560-7917.ES.2021.26.48.2101040 <pub-id pub-id-type="doi">10.2807/1560-7917.ES.2021.26.48.2101040</pub-id><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.2807/1560-7917.ES.2021.26.48.2101040">https://doi.org/10.2807/1560-7917.ES.2021.26.48.2101040</ext-link></mixed-citation>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <string-name>Indenbaum, V.</string-name>
              <string-name>Lustig, Y.</string-name>
              <string-name>Mendelson, E.</string-name>
              <string-name>Hershkovitz, Y.</string-name>
              <string-name>Glatman-Freedman, A.</string-name>
              <string-name>Keinan-Boker, L.</string-name>
              <string-name>Study, I</string-name>
            </person-group>
            <year>2021</year>
            <article-title>Under-Diagnosis of SARS-CoV-2 Infections among Children Aged 0-15 Years, a Nationwide Seroprevalence Study, Israel, January 2020 to March 2021</article-title>
            <source>Eurosurveillance</source>
            <volume>26</volume>
            <fpage>210104</fpage>
            <elocation-id>ID</elocation-id>
            <pub-id pub-id-type="doi">10.2807/1560-7917.ES.2021.26.48.2101040</pub-id>
          </element-citation>
        </citation-alternatives>
      </ref>
      <ref id="B26">
        <label>26.</label>
        <citation-alternatives>
          <mixed-citation publication-type="journal">Ferreira, M.U., Giacomini, I., Sato, P.M., Lourenço, B.H., Nicolete, V.C., Buss, L.F., <italic>et al</italic>. (2022) SARS-CoV-2 Seropositivity and COVID-19 among 5 Years-Old Amazonian Children and Their Association with Poverty and Food Insecurity. <italic>PLOS Neglected Tropical Diseases</italic>, 16, e0010580. https://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0010580 https://doi.org/10.1371/journal.pntd.0010580 <pub-id pub-id-type="doi">10.1371/journal.pntd.0010580</pub-id><pub-id pub-id-type="pmid">35849564</pub-id><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pntd.0010580">https://doi.org/10.1371/journal.pntd.0010580</ext-link></mixed-citation>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <string-name>Ferreira, M.U.</string-name>
              <string-name>Giacomini, I.</string-name>
              <string-name>Sato, P.M.</string-name>
              <string-name>Nicolete, V.C.</string-name>
              <string-name>Buss, L.F.</string-name>
            </person-group>
            <year>2022</year>
            <article-title>SARS-CoV-2 Seropositivity and COVID-19 among 5 Years-Old Amazonian Children and Their Association with Poverty and Food Insecurity</article-title>
            <source>PLOS Neglected Tropical Diseases</source>
            <volume>16</volume>
            <pub-id pub-id-type="doi">10.1371/journal.pntd.0010580</pub-id>
            <pub-id pub-id-type="pmid">35849564</pub-id>
          </element-citation>
        </citation-alternatives>
      </ref>
    </ref-list>
  </back>
</article>